HELXETF / FundFranklin Genomic Advancements ETF
Verdicts genuinely change. Free email alert the moment HELX's does — no target price to set, unlike a price alert.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Franklin Genomic Advancements ETF ETF · Franklin Templeton ETF Trust
63 holdings · as of 2026-06-30 (4.5 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.
NON-COMPLIANT 22.13% of portfolio weight is in non-compliant holdings, over the 5% threshold.
63 holdings, 55 matched (91% of weight). Portfolio as of 2026-06-30, filed 2026-08-27. Source: SEC Form N-PORT.
4.26% of this portfolio’s income is non-permissible — weighted across holdings, computed over 79% of portfolio weight (48 of 63 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
67.8% compliant 0.0% questionable 22.1% non-compliant 8.8% unscreened
All holdings (63)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| GH GUARDANT HEALTH INC | COMPLIANT | 9.09% | AAOIFI7.8% Usmani88.7% Dow Jones Islamic17.9% S&P Shariah23.1% MSCI Islamic88.7% MSCI Islamic M-Series23.1% FTSE Shariah78.6% |
| NTRA NATERA INC | COMPLIANT | 7.46% | AAOIFI0.5% Usmani9.0% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic9.0% MSCI Islamic M-Series1.2% FTSE Shariah3.0% |
| KRYS KRYSTAL BIOTECH INC | NON_COMPLIANT | 6.33% | AAOIFI0.1% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.5% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| LGND LIGAND PHARMACEUTICALS INC | COMPLIANT | 4.62% | AAOIFI19.7% Usmani51.8% Dow Jones Islamic34.1% S&P Shariah42.6% MSCI Islamic51.8% MSCI Islamic M-Series42.6% FTSE Shariah51.5% |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | COMPLIANT | 3.99% | AAOIFI2.0% Usmani11.8% Dow Jones Islamic3.9% S&P Shariah5.1% MSCI Islamic11.8% MSCI Islamic M-Series5.1% FTSE Shariah0.0% |
| UTHR UNITED THERAPEUTICS CORP | NON_COMPLIANT | 3.51% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| BBIO BRIDGEBIO PHARMA INC | COMPLIANT | 3.50% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| LLY ELI LILLY & COMPANY | COMPLIANT | 2.95% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| TWST TWIST BIOSCIENCE CORP | COMPLIANT | 2.85% | AAOIFI1.1% Usmani13.9% Dow Jones Islamic3.2% S&P Shariah3.5% MSCI Islamic13.9% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| VRTX VERTEX PHARMACEUTICALS INC | COMPLIANT | 2.75% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| AZN ASTRAZENECA PLC | COMPLIANT | 2.70% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| TVTX TRAVERE THERAPEUTICS INC | COMPLIANT | 2.59% | AAOIFI10.0% Usmani77.2% Dow Jones Islamic24.4% S&P Shariah32.6% MSCI Islamic77.2% MSCI Islamic M-Series32.6% FTSE Shariah75.4% |
| INSMED INC | UNSCREENED | 2.44% | no in-house ratios for this holding |
| SAMSUNG BIOLOGICS CO LTD | UNSCREENED | 2.26% | no in-house ratios for this holding |
| CTVA CORTEVA INC | COMPLIANT | 2.25% | AAOIFI2.9% Usmani4.0% Dow Jones Islamic3.6% S&P Shariah3.9% MSCI Islamic4.0% MSCI Islamic M-Series3.9% FTSE Shariah4.0% |
| MEDP MEDPACE HOLDINGS INC | COMPLIANT | 2.15% | AAOIFIpass Usmani— Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariah— |
| ALNY ALNYLAM PHARMACEUTICALS INC | COMPLIANT | 1.96% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| TEM TEMPUS AI INC | COMPLIANT | 1.95% | AAOIFI0.7% Usmani3.5% Dow Jones Islamic0.8% S&P Shariahpass MSCI Islamic3.5% MSCI Islamic M-Seriespass FTSE Shariah0.0% |
| IONS IONIS PHARMACEUTICALS INC | NON_COMPLIANT | 1.91% | AAOIFI21.0% Usmani67.5% Dow Jones Islamic23.0% S&P Shariah25.1% MSCI Islamic67.5% MSCI Islamic M-Series25.1% FTSE Shariah58.8% |
| NBIX NEUROCRINE BIOSCIENCES INC | COMPLIANT | 1.84% | AAOIFI2.9% Usmani8.6% Dow Jones Islamic3.4% S&P Shariah3.5% MSCI Islamic8.6% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| REGN REGENERON PHARMACEUTICALS INC | COMPLIANT | 1.80% | AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8% |
| VCYT VERACYTE INC | COMPLIANT | 1.64% | AAOIFI1.1% Usmani2.7% Dow Jones Islamic1.4% S&P Shariah1.6% MSCI Islamic2.7% MSCI Islamic M-Series1.6% FTSE Shariah0.0% |
| ARGX ARGENX SE | COMPLIANT | 1.64% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| PTCT PTC THERAPEUTICS INC | NON_COMPLIANT | 1.46% | AAOIFI11.9% Usmani21.4% Dow Jones Islamic16.9% S&P Shariah20.0% MSCI Islamic21.2% MSCI Islamic M-Series20.0% FTSE Shariah18.2% |
| 22UA.DE BIONTECH SE | NON_COMPLIANT | 1.38% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| STOK STOKE THERAPEUTICS INC | NON_COMPLIANT | 1.33% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC | COMPLIANT | 1.26% | AAOIFI21.2% Usmani40.3% Dow Jones Islamic33.1% S&P Shariah30.9% MSCI Islamic40.3% MSCI Islamic M-Series30.9% FTSE Shariah34.9% |
| GRAL GRAIL INC | NON_COMPLIANT | 1.09% | AAOIFI2.5% Usmani3.2% Dow Jones Islamic4.7% S&P Shariahfail MSCI Islamic3.2% MSCI Islamic M-Seriesfail FTSE Shariah0.0% |
| ANAPTYSBIO INC | UNSCREENED | 1.04% | no in-house ratios for this holding |
| CRSP CRISPR THERAPEUTICS AG | NON_COMPLIANT | 0.98% | AAOIFI15.5% Usmani29.6% Dow Jones Islamic17.0% S&P Shariah16.8% MSCI Islamic29.6% MSCI Islamic M-Series16.8% FTSE Shariah22.1% |
| RGEN REPLIGEN CORP | COMPLIANT | 0.98% | AAOIFI7.3% Usmani23.4% Dow Jones Islamic8.8% S&P Shariah8.4% MSCI Islamic23.4% MSCI Islamic M-Series8.4% FTSE Shariah18.7% |
| CDNS CADENCE DESIGN SYSTEMS INC | COMPLIANT | 0.97% | AAOIFI0.3% Usmani1.9% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic1.9% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| BEAM BEAM THERAPEUTICS INC | NON_COMPLIANT | 0.93% | AAOIFI8.2% Usmani17.8% Dow Jones Islamic10.4% S&P Shariah10.7% MSCI Islamic17.8% MSCI Islamic M-Series10.7% FTSE Shariah7.2% |
| PRAXIS PRECISION MEDICINES INC | UNSCREENED | 0.86% | no in-house ratios for this holding |
| SARTORIUS AG | UNSCREENED | 0.85% | no in-house ratios for this holding |
| AXSM AXSOME THERAPEUTICS INC | COMPLIANT | 0.82% | AAOIFI1.9% Usmani29.5% Dow Jones Islamic2.9% S&P Shariah3.5% MSCI Islamic27.6% MSCI Islamic M-Series3.5% FTSE Shariah24.7% |
| CDNA CAREDX INC | COMPLIANT | 0.82% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| JAZZ JAZZ PHARMACEUTICALS PLC | NON_COMPLIANT | 0.78% | AAOIFI38.6% Usmani46.9% Dow Jones Islamic55.2% S&P Shariah61.2% MSCI Islamic46.9% MSCI Islamic M-Series61.2% FTSE Shariah46.4% |
| CATALYST PHARMACEUTICALS INC | UNSCREENED | 0.77% | no in-house ratios for this holding |
| TMO THERMO FISHER SCIENTIFIC INC | COMPLIANT | 0.76% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| IQV IQVIA HOLDINGS INC | NON_COMPLIANT | 0.75% | AAOIFI36.7% Usmani55.2% Dow Jones Islamic47.8% S&P Shariah44.8% MSCI Islamic54.4% MSCI Islamic M-Series44.8% FTSE Shariah53.4% |
| HNGE HINGE HEALTH INC | COMPLIANT | 0.70% | AAOIFI0.1% Usmani0.7% Dow Jones Islamicpass S&P Shariahpass MSCI Islamic0.7% MSCI Islamic M-Seriespass FTSE Shariah0.0% |
| RARE ULTRAGENYX PHARMACEUTICAL INC | NON_COMPLIANT | 0.61% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| A AGILENT TECHNOLOGIES INC | COMPLIANT | 0.58% | AAOIFI9.3% Usmani28.3% Dow Jones Islamic10.8% S&P Shariah10.7% MSCI Islamic28.3% MSCI Islamic M-Series10.7% FTSE Shariah28.3% |
| DHR DANAHER CORP | COMPLIANT | 0.57% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| QGEN QIAGEN NV | COMPLIANT | 0.48% | AAOIFI20.8% Usmani28.9% Dow Jones Islamic18.9% S&P Shariah18.9% MSCI Islamic28.9% MSCI Islamic M-Series18.9% FTSE Shariah26.3% |
| RYTM RHYTHM PHARMACEUTICALS INC | NON_COMPLIANT | 0.42% | AAOIFI1.8% Usmani25.1% Dow Jones Islamic2.0% S&P Shariah2.4% MSCI Islamic25.1% MSCI Islamic M-Series2.4% FTSE Shariah24.3% |
| ARQT ARCUTIS BIOTHERAPEUTICS INC | COMPLIANT | 0.42% | AAOIFI3.8% Usmani23.4% Dow Jones Islamic5.0% S&P Shariah6.5% MSCI Islamic23.4% MSCI Islamic M-Series6.5% FTSE Shariah22.3% |
| SAMSUNG EPIS HOLDINGS CO LTD | UNSCREENED | 0.37% | no in-house ratios for this holding |
| KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | COMPLIANT | 0.34% | AAOIFI0.2% Usmani1.1% Dow Jones Islamic0.3% S&P Shariah0.4% MSCI Islamic1.1% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| TARS TARSUS PHARMACEUTICALS INC | COMPLIANT | 0.26% | AAOIFI2.3% Usmani14.5% Dow Jones Islamic3.8% S&P Shariah4.7% MSCI Islamic14.5% MSCI Islamic M-Series4.7% FTSE Shariah11.9% |
| BIO BIO-RAD LABORATORIES INC | COMPLIANT | 0.26% | AAOIFI9.3% Usmani9.5% Dow Jones Islamic11.8% S&P Shariah11.6% MSCI Islamic9.5% MSCI Islamic M-Series11.6% FTSE Shariah7.8% |
| LQDA LIQUIDIA CORP | COMPLIANT | 0.25% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| BMY BRISTOL-MYERS SQUIBB COMPANY | NON_COMPLIANT | 0.25% | AAOIFI37.3% Usmani51.1% Dow Jones Islamic42.2% S&P Shariah44.8% MSCI Islamic51.1% MSCI Islamic M-Series44.8% FTSE Shariah48.9% |
| TGTX TG THERAPEUTICS INC | COMPLIANT | 0.25% | AAOIFI8.8% Usmani46.0% Dow Jones Islamic13.7% S&P Shariah17.0% MSCI Islamic46.0% MSCI Islamic M-Series17.0% FTSE Shariah45.5% |
| ONC BEONE MEDICINES LTD | COMPLIANT | 0.23% | AAOIFI2.8% Usmani12.5% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic12.5% MSCI Islamic M-Series0.3% FTSE Shariah11.7% |
| NGNE NEUROGENE INC | NON_COMPLIANT | 0.22% | AAOIFI1.1% Usmani3.4% Dow Jones Islamic2.2% S&P Shariah2.5% MSCI Islamic3.4% MSCI Islamic M-Series2.5% FTSE Shariah0.0% |
| FIRST TRACKS BIOTHERAPEUTICS INC | UNSCREENED | 0.20% | no in-house ratios for this holding |
| WGS GENEDX HOLDINGS CORP | COMPLIANT | 0.14% | AAOIFI4.7% Usmani20.1% Dow Jones Islamic3.9% S&P Shariah5.5% MSCI Islamic20.1% MSCI Islamic M-Series5.5% FTSE Shariah20.1% |
| WVE WAVE LIFE SCIENCES LTD | NON_COMPLIANT | 0.10% | AAOIFI3.9% Usmani7.8% Dow Jones Islamic2.9% S&P Shariah3.6% MSCI Islamic7.8% MSCI Islamic M-Series3.6% FTSE Shariah0.0% |
| RXRX RECURSION PHARMACEUTICALS INC | NON_COMPLIANT | 0.07% | AAOIFI3.4% Usmani5.5% Dow Jones Islamic7.3% S&P Shariah6.1% MSCI Islamic5.5% MSCI Islamic M-Series6.1% FTSE Shariah1.2% |
| OABI OMNIAB INC | NON_COMPLIANT | 0.00% | AAOIFI3.0% Usmani6.5% Dow Jones Islamic5.9% S&P Shariah4.7% MSCI Islamic6.5% MSCI Islamic M-Series4.7% FTSE Shariah0.0% |
| OABI OMNIAB INC | NON_COMPLIANT | 0.00% | AAOIFI3.0% Usmani6.5% Dow Jones Islamic5.9% S&P Shariah4.7% MSCI Islamic6.5% MSCI Islamic M-Series4.7% FTSE Shariah0.0% |
The published standards disagree about this fund by 44 points of portfolio weight — 50.5% of it passes AAOIFI, 7.0% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 50.5% ratios fail on 15.8% 32.4% not rated under AAOIFI
ratios pass on 20.5% ratios fail on 33.2% 45.0% not rated under Usmani
ratios pass on 48.5% ratios fail on 17.0% 33.2% not rated under Dow Jones Islamic
ratios pass on 49.8% ratios fail on 15.8% 33.2% not rated under S&P Shariah
ratios pass on 7.0% ratios fail on 56.1% 35.7% not rated under MSCI Islamic
ratios pass on 49.8% ratios fail on 15.8% 33.2% not rated under MSCI Islamic M-Series
ratios pass on 20.5% ratios fail on 33.2% 45.0% not rated under FTSE Shariah
54 of 63 listed holdings carry our own per-methodology verdicts (90% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 47 (76% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| KRYS KRYSTAL BIOTECH INC | 6.33% |
| UTHR UNITED THERAPEUTICS CORP | 3.51% |
| IONS IONIS PHARMACEUTICALS INC | 1.91% |
| PTCT PTC THERAPEUTICS INC | 1.46% |
| 22UA.DE BIONTECH SE | 1.38% |
| STOK STOKE THERAPEUTICS INC | 1.33% |
| GRAL GRAIL INC | 1.09% |
| CRSP CRISPR THERAPEUTICS AG | 0.98% |
| BEAM BEAM THERAPEUTICS INC | 0.93% |
| JAZZ JAZZ PHARMACEUTICALS PLC | 0.78% |
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Franklin Genomic Advancements ETF (HELX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for HELX — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 47.90 | NEUTRAL |
| Stochastic %K (14) | 34.72 | NEUTRAL |
| CCI (20) | -37.41 | NEUTRAL |
| Williams %R (14) | -65.28 | NEUTRAL |
| MACD (12,26,9) | -0.12 | SELL |
| ROC (10) | -6.64 | SELL |
| Momentum (10) | -3.05 | SELL |
| EMA (10) | 43.54 | SELL |
| SMA (10) | 43.68 | SELL |
| EMA (20) | 43.50 | SELL |
| SMA (20) | 43.52 | SELL |
| EMA (30) | 43.36 | SELL |
| SMA (30) | 43.26 | SELL |
| EMA (50) | 42.91 | BUY |
| SMA (50) | 43.08 | SELL |
| EMA (100) | 41.52 | BUY |
| SMA (100) | 41.79 | BUY |
| EMA (200) | 39.07 | BUY |
| SMA (200) | 37.95 | BUY |
About Franklin Genomic Advancements ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Background via Yahoo Finance — informational, not part of the verdict.
Average — needs more confirmation before sizing up
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 44 |
| ⏱ 15-Min | NEUTRAL | 15 |
| ⏲ 5-Min | BEARISH | 45 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-03 · Asset managers net 928584 (+5135)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.